Interstitial lung disease, airway disease, chronic obstructive pulmonary disease, asthma, bronchiectasis, chronic bronchitis
Conditions
Interventions
Nonspecific interstitial pneumonia, NSIP:NA
NSIP-airway diseases:NA
COPD-ILA:NA
asthma-ILA:NA
Idiopathic pulmonary fibrosis:NA
chronic obstructive pulmonary disease, COPD:NA
Idiopathic pulmonary fibrosis combined with airway disease:NA
Sponsors
Xiangya Hospital Central South University
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria in Part I: 1. discharge from respiratory and critical care unit within the previous 12 months (2024 february-february 2025) ; 2. cases with a discharge diagnosis that included an interstitial lung disease and/or airway disease diagnosis (ICD-10) ; 3. cases with complete medical record information. The second part of the inclusion criteria: 1. Age 40-75 years old (including 40 years old, 75 years old) ; 2. Screening of inpatient admissions for COPD, asthma, Idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, or outpatient visits, cOPD, asthma, Idiopathic pulmonary fibrosis, non-specific interstitial pneumonia, COPD with interstitial lung disease, asthma with interstitial lung disease, Idiopathic pulmonary fibrosis with airway disease, and non-specific interstitial pneumonia with airway disease were diagnosed by chest CT (< 1.5 mm thickness) and pulmonary function during hospitalization (see Table 2) ; 3. Screening of hospitalized patients for COPD, asthma, Idiopathic pulmonary fibrosis, and nonspecific interstitial pneumonia at admission, cOPD, asthma, Idiopathic pulmonary fibrosis, non-specific interstitial pneumonia, COPD with pulmonary interstitial abnormalities, asthma with pulmonary interstitial abnormalities, Idiopathic pulmonary fibrosis with airway lesions, and non-specific interstitial pneumonia with airway lesions were diagnosed by chest CT (slice thickness < 1.5 mm) during hospitalization combined with previous pulmonary function (see Table 2) ; 4. Pulmonary function and chest HRCT could be completed 1 month after discharge; 5. informed consent was provided. The third part of the inclusion criteria: 1. physical examination of chest CT, lung function found suspected interstitial lung disease or airway disease patients, the need to transfer respiratory specialist diagnosis (see Table 4) , and by specialist assessment need to receive treatment; 2. patients with imaging progression of pulmonary interstitial abnormalities on chest CT (increased area of pulmonary interstitial abnormalities, or new types of interstitial abnormalities) ; 3. providing informed consent.
Exclusion criteria
Exclusion criteria: Part I exclusion criteria: no chest CT results; Part II exclusion criteria: 1. expected survival less than 12 months, 2. planned lung transplantation or pneumonectomy within 12 months, 3. pregnant or lactating women. Part III exclusion criteria: 1. expected survival less than 12 months; 2. planned lung transplantation or pneumonectomy within 12 months; 3. pregnant or lactating female.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Annual rate/value of decline in lung function;Advances in chest imaging; | — |
Secondary
| Measure | Time frame |
|---|---|
| acute exacerbations;survival status;symptom assessment; | — |
Countries
China
Contacts
Public ContactRuoxi He
Xiangya Hospital Central South University
Outcome results
None listed